[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f6jmoDJXOapnRttqGwLfP2TYIsvTNcekcUoICyjdZ7nI":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":58,"rows":65},"Chiang Mai University",[4],117,false,14,19,23046,9,77,[14,17,20,22,24,26,28,30],{"name":15,"count":16},"Vaccine-Preventable Diseases",4,{"name":18,"count":19},"Hepatitis A",3,{"name":21,"count":19},"Hepatitis B",{"name":23,"count":19},"Mild Cognitive Impairment",{"name":25,"count":19},"HIV Infection",{"name":27,"count":19},"Acute Kidney Injury",{"name":29,"count":19},"Peritoneal Dialysis",{"name":31,"count":19},"Hypertension",[33,38,43,48,53],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT06570850","Colistin Monotherapy vs Colsitin-fosfomycine in CRAB Infection","2025-03","Colistin Sodium Methanesulfonate",{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT06978621","Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV","2025-06-22","Inactivated hepatitis A vaccine",{"nctId":44,"briefTitle":45,"date":46,"intervention":47},"NCT06748014","The Efficacy of Aescin in Combination With Micronized Purified Flavonoid Fraction (MPFF) in the Control of Bleeding and Prevent Recurrence of Acute Internal Hemorrhoids, A Randomized Controlled Trial, A Pilot Study","2025-07","Aescin in Horse Chestnut",{"nctId":49,"briefTitle":50,"date":51,"intervention":52},"NCT06229990","A Protocol Based-Furosemide Stress Test to Evaluate Renal Recovery During Continuous Renal Replacement Therapy","2028-12-31","Furosemide",{"nctId":54,"briefTitle":55,"date":56,"intervention":57},"NCT07621341","Maternal Immunization With Tetanus Toxoid, Reduced Diphtheria Toxoid, Reduced-dose (2 µg) Recombinant Pertussis Vaccine (TdaP2gen) and Its Effect on the Immune Response in Thai Infants up to 15-18 Months Old","2029-12-31","Maternal TdaP2gen vaccine",[59,60,61,62,63,64],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[66,95,113,131,154,172,192,215,239,270,306,339,378,400,427,445,472,496,522,550,568,595,613,639,665,692,710,733,759,782,808,826,851,879,897,924,942,966,991,1016,1041,1059,1086,1112,1140,1165,1183,1208,1235,1253,1271,1296],{"intervention":57,"totalTrials":67,"cells":68},1,{"EARLY_PHASE1":69,"PHASE1":72,"PHASE2":74,"PHASE3":76,"PHASE4":78,"NA":93},{"trials":70,"activeCount":71},[],0,{"trials":73,"activeCount":71},[],{"trials":75,"activeCount":71},[],{"trials":77,"activeCount":71},[],{"trials":79,"activeCount":67,"soonestReadout":56},[80],{"nctId":54,"briefTitle":55,"status":81,"phases":82,"primaryCompletion":56,"completion":83,"start":84,"enrollment":85,"conditions":86,"interventions":90},"NOT_YET_RECRUITING",[63],"2030-12-31","2026-05-26",320,[87,88,89,15],"Pertussis","Diphtheria","Tetanus",[57,91,92],"Infant Acellular Pertussis-containing Vaccine","Infant Whole-cell Pertussis-containing Vaccine",{"trials":94,"activeCount":71},[],{"intervention":91,"totalTrials":67,"cells":96},{"EARLY_PHASE1":97,"PHASE1":99,"PHASE2":101,"PHASE3":103,"PHASE4":105,"NA":111},{"trials":98,"activeCount":71},[],{"trials":100,"activeCount":71},[],{"trials":102,"activeCount":71},[],{"trials":104,"activeCount":71},[],{"trials":106,"activeCount":67,"soonestReadout":56},[107],{"nctId":54,"briefTitle":55,"status":81,"phases":108,"primaryCompletion":56,"completion":83,"start":84,"enrollment":85,"conditions":109,"interventions":110},[63],[87,88,89,15],[57,91,92],{"trials":112,"activeCount":71},[],{"intervention":92,"totalTrials":67,"cells":114},{"EARLY_PHASE1":115,"PHASE1":117,"PHASE2":119,"PHASE3":121,"PHASE4":123,"NA":129},{"trials":116,"activeCount":71},[],{"trials":118,"activeCount":71},[],{"trials":120,"activeCount":71},[],{"trials":122,"activeCount":71},[],{"trials":124,"activeCount":67,"soonestReadout":56},[125],{"nctId":54,"briefTitle":55,"status":81,"phases":126,"primaryCompletion":56,"completion":83,"start":84,"enrollment":85,"conditions":127,"interventions":128},[63],[87,88,89,15],[57,91,92],{"trials":130,"activeCount":71},[],{"intervention":37,"totalTrials":67,"cells":132},{"EARLY_PHASE1":133,"PHASE1":135,"PHASE2":137,"PHASE3":139,"PHASE4":141,"NA":152},{"trials":134,"activeCount":71},[],{"trials":136,"activeCount":71},[],{"trials":138,"activeCount":71},[],{"trials":140,"activeCount":71},[],{"trials":142,"activeCount":67,"soonestReadout":36},[143],{"nctId":34,"briefTitle":35,"status":144,"phases":145,"primaryCompletion":36,"completion":46,"start":146,"enrollment":147,"conditions":148,"interventions":150},"RECRUITING",[63],"2023-04-01",188,[149],"Infection Due to Carbapenem Resistant Acinetobacter",[37,151],"Colistin Sodium Methanesulfonate plus Fosfomycin",{"trials":153,"activeCount":71},[],{"intervention":151,"totalTrials":67,"cells":155},{"EARLY_PHASE1":156,"PHASE1":158,"PHASE2":160,"PHASE3":162,"PHASE4":164,"NA":170},{"trials":157,"activeCount":71},[],{"trials":159,"activeCount":71},[],{"trials":161,"activeCount":71},[],{"trials":163,"activeCount":71},[],{"trials":165,"activeCount":67,"soonestReadout":36},[166],{"nctId":34,"briefTitle":35,"status":144,"phases":167,"primaryCompletion":36,"completion":46,"start":146,"enrollment":147,"conditions":168,"interventions":169},[63],[149],[37,151],{"trials":171,"activeCount":71},[],{"intervention":52,"totalTrials":67,"cells":173},{"EARLY_PHASE1":174,"PHASE1":176,"PHASE2":178,"PHASE3":180,"PHASE4":182,"NA":190},{"trials":175,"activeCount":71},[],{"trials":177,"activeCount":71},[],{"trials":179,"activeCount":71},[],{"trials":181,"activeCount":71},[],{"trials":183,"activeCount":67,"soonestReadout":51},[184],{"nctId":49,"briefTitle":50,"status":144,"phases":185,"primaryCompletion":51,"completion":51,"start":186,"enrollment":187,"conditions":188,"interventions":189},[63],"2024-01-01",80,[27],[52],{"trials":191,"activeCount":71},[],{"intervention":42,"totalTrials":67,"cells":193},{"EARLY_PHASE1":194,"PHASE1":196,"PHASE2":198,"PHASE3":200,"PHASE4":211,"NA":213},{"trials":195,"activeCount":71},[],{"trials":197,"activeCount":71},[],{"trials":199,"activeCount":71},[],{"trials":201,"activeCount":67,"soonestReadout":41},[202],{"nctId":39,"briefTitle":40,"status":203,"phases":204,"primaryCompletion":41,"completion":205,"start":206,"enrollment":207,"conditions":208,"interventions":210},"ACTIVE_NOT_RECRUITING",[62],"2026-07-31","2025-05-25",36,[18,209,15],"Hepatitis A Virus",[42],{"trials":212,"activeCount":71},[],{"trials":214,"activeCount":71},[],{"intervention":216,"totalTrials":67,"cells":217},"MPFF",{"EARLY_PHASE1":218,"PHASE1":229,"PHASE2":231,"PHASE3":233,"PHASE4":235,"NA":237},{"trials":219,"activeCount":67,"soonestReadout":46},[220],{"nctId":44,"briefTitle":45,"status":221,"phases":222,"primaryCompletion":46,"completion":223,"start":224,"enrollment":225,"conditions":226,"interventions":228},"ENROLLING_BY_INVITATION",[59],"2025-12","2024-12-20",120,[227],"Hemorrhoid",[47,216],{"trials":230,"activeCount":71},[],{"trials":232,"activeCount":71},[],{"trials":234,"activeCount":71},[],{"trials":236,"activeCount":71},[],{"trials":238,"activeCount":71},[],{"intervention":47,"totalTrials":240,"cells":241},2,{"EARLY_PHASE1":242,"PHASE1":248,"PHASE2":250,"PHASE3":252,"PHASE4":254,"NA":256},{"trials":243,"activeCount":67,"soonestReadout":46},[244],{"nctId":44,"briefTitle":45,"status":221,"phases":245,"primaryCompletion":46,"completion":223,"start":224,"enrollment":225,"conditions":246,"interventions":247},[59],[227],[47,216],{"trials":249,"activeCount":71},[],{"trials":251,"activeCount":71},[],{"trials":253,"activeCount":71},[],{"trials":255,"activeCount":71},[],{"trials":257,"activeCount":71},[258],{"nctId":259,"briefTitle":260,"status":261,"phases":262,"primaryCompletion":263,"completion":263,"start":264,"enrollment":265,"conditions":266,"interventions":268},"NCT06363513","The Efficacy of Aescin in Combination With MPFF in the Early Control of Bleeding From Acute Internal Hemorrhoids, A Randomized Controlled Trial","UNKNOWN",[64],"2024-05","2024-04",60,[267],"Anorectal Disorder",[47,269],"Flavonoid",{"intervention":271,"totalTrials":240,"cells":272},"Topiramate",{"EARLY_PHASE1":273,"PHASE1":275,"PHASE2":277,"PHASE3":279,"PHASE4":293,"NA":304},{"trials":274,"activeCount":71},[],{"trials":276,"activeCount":71},[],{"trials":278,"activeCount":71},[],{"trials":280,"activeCount":71},[281],{"nctId":282,"briefTitle":283,"status":284,"phases":285,"primaryCompletion":286,"completion":287,"start":288,"enrollment":289,"conditions":290,"interventions":292},"NCT01145677","Efficacy of Topiramate for Hospitalized Patients With Alcoholism","COMPLETED",[61,62],"2011-03","2011-06","2010-06",90,[291],"Alcohol Dependence",[271],{"trials":294,"activeCount":71},[295],{"nctId":296,"briefTitle":297,"status":261,"phases":298,"primaryCompletion":299,"completion":299,"start":300,"enrollment":301,"conditions":302,"interventions":303},"NCT01135602","Topiramate for Hospitalized Patients With Alcoholism: a 12-week Study",[63],"2012-03","2010-07",150,[291],[271],{"trials":305,"activeCount":71},[],{"intervention":307,"totalTrials":240,"cells":308},"Hepatitis B vaccine",{"EARLY_PHASE1":309,"PHASE1":311,"PHASE2":313,"PHASE3":315,"PHASE4":317,"NA":337},{"trials":310,"activeCount":71},[],{"trials":312,"activeCount":71},[],{"trials":314,"activeCount":71},[],{"trials":316,"activeCount":71},[],{"trials":318,"activeCount":71},[319,328],{"nctId":320,"briefTitle":321,"status":261,"phases":322,"primaryCompletion":323,"completion":324,"start":325,"enrollment":187,"conditions":326,"interventions":327},"NCT03219203","Immunologic Response of Hepatitis B Vaccine",[63],"2018-07-01","2018-10-01","2017-07-01",[21],[307],{"nctId":329,"briefTitle":330,"status":261,"phases":331,"primaryCompletion":332,"completion":323,"start":325,"enrollment":333,"conditions":334,"interventions":336},"NCT03212911","HBV Vaccination in HIV-infected Adults",[63],"2018-02-01",96,[335],"Hepatitis B Vaccination, HIV",[307],{"trials":338,"activeCount":71},[],{"intervention":340,"totalTrials":240,"cells":341},"Dexamethasone",{"EARLY_PHASE1":342,"PHASE1":344,"PHASE2":346,"PHASE3":348,"PHASE4":350,"NA":376},{"trials":343,"activeCount":71},[],{"trials":345,"activeCount":71},[],{"trials":347,"activeCount":71},[],{"trials":349,"activeCount":71},[],{"trials":351,"activeCount":71},[352,363],{"nctId":353,"briefTitle":354,"status":261,"phases":355,"primaryCompletion":356,"start":357,"enrollment":358,"conditions":359,"interventions":361},"NCT02760459","Effects of Perioperative Intravenous Dexamethasone on the Severity of Persistent Postsurgical Pain After Total Knee Arthroplasty : A Prospective, Randomized, Double-blind, Placebo-controlled Trial",[63],"2017-06","2016-10",70,[360],"Osteoarthritis of the Knee",[340,362],"Normal saline solution",{"nctId":364,"briefTitle":365,"status":261,"phases":366,"primaryCompletion":367,"completion":368,"start":369,"enrollment":370,"conditions":371,"interventions":374},"NCT03542617","Effect of Preoperative Intravenous Dexamethasone on Postoperative Pain After Primary Total Hip Arthroplasty",[63],"2019-12-31","2020-12-31","2016-10-05",57,[372,373],"Localized Primary Osteoarthritis of Both Hips (Diagnosis)","Osteoarthritis, Hip",[340,375],"Normal Saline Solution",{"trials":377,"activeCount":71},[],{"intervention":362,"totalTrials":240,"cells":379},{"EARLY_PHASE1":380,"PHASE1":382,"PHASE2":384,"PHASE3":386,"PHASE4":388,"NA":398},{"trials":381,"activeCount":71},[],{"trials":383,"activeCount":71},[],{"trials":385,"activeCount":71},[],{"trials":387,"activeCount":71},[],{"trials":389,"activeCount":71},[390,394],{"nctId":353,"briefTitle":354,"status":261,"phases":391,"primaryCompletion":356,"start":357,"enrollment":358,"conditions":392,"interventions":393},[63],[360],[340,362],{"nctId":364,"briefTitle":365,"status":261,"phases":395,"primaryCompletion":367,"completion":368,"start":369,"enrollment":370,"conditions":396,"interventions":397},[63],[372,373],[340,375],{"trials":399,"activeCount":71},[],{"intervention":401,"totalTrials":67,"cells":402},"vildagliptin",{"EARLY_PHASE1":403,"PHASE1":405,"PHASE2":407,"PHASE3":409,"PHASE4":411,"NA":425},{"trials":404,"activeCount":71},[],{"trials":406,"activeCount":71},[],{"trials":408,"activeCount":71},[],{"trials":410,"activeCount":71},[],{"trials":412,"activeCount":71},[413],{"nctId":414,"briefTitle":415,"status":284,"phases":416,"primaryCompletion":417,"completion":417,"start":418,"enrollment":419,"conditions":420,"interventions":423},"NCT03178591","Effects of DPP4 Inhibitor Versus SGLT2 Inhibitor",[63],"2018-07","2014-10",43,[421,422],"Diabetes Mellitus, Type 2","Ischemic Heart Disease",[401,424],"Dapagliflozin",{"trials":426,"activeCount":71},[],{"intervention":424,"totalTrials":67,"cells":428},{"EARLY_PHASE1":429,"PHASE1":431,"PHASE2":433,"PHASE3":435,"PHASE4":437,"NA":443},{"trials":430,"activeCount":71},[],{"trials":432,"activeCount":71},[],{"trials":434,"activeCount":71},[],{"trials":436,"activeCount":71},[],{"trials":438,"activeCount":71},[439],{"nctId":414,"briefTitle":415,"status":284,"phases":440,"primaryCompletion":417,"completion":417,"start":418,"enrollment":419,"conditions":441,"interventions":442},[63],[421,422],[401,424],{"trials":444,"activeCount":71},[],{"intervention":446,"totalTrials":67,"cells":447},"Clopidogrel",{"EARLY_PHASE1":448,"PHASE1":450,"PHASE2":452,"PHASE3":454,"PHASE4":456,"NA":470},{"trials":449,"activeCount":71},[],{"trials":451,"activeCount":71},[],{"trials":453,"activeCount":71},[],{"trials":455,"activeCount":71},[],{"trials":457,"activeCount":71},[458],{"nctId":459,"briefTitle":460,"status":261,"phases":461,"primaryCompletion":462,"completion":462,"start":463,"enrollment":464,"conditions":465,"interventions":469},"NCT03103685","Continue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving DAPT Undergoing Dental Procedure.",[63],"2018-12-30","2017-05-01",428,[466,467,468],"Dental Diseases","Antiplatelet Agents","Antiplatelet Drugs",[446],{"trials":471,"activeCount":71},[],{"intervention":473,"totalTrials":67,"cells":474},"recombinant HBV vaccine",{"EARLY_PHASE1":475,"PHASE1":477,"PHASE2":479,"PHASE3":481,"PHASE4":483,"NA":494},{"trials":476,"activeCount":71},[],{"trials":478,"activeCount":71},[],{"trials":480,"activeCount":71},[],{"trials":482,"activeCount":71},[],{"trials":484,"activeCount":71},[485],{"nctId":486,"briefTitle":487,"status":284,"phases":488,"primaryCompletion":489,"completion":489,"start":490,"enrollment":491,"conditions":492,"interventions":493},"NCT02713620","Hepatitis B Vaccination in HIV-infected Adults",[63],"2016-01","2015-01",154,[21],[473],{"trials":495,"activeCount":71},[],{"intervention":497,"totalTrials":67,"cells":498},"0.5 ml of MMR vaccine",{"EARLY_PHASE1":499,"PHASE1":501,"PHASE2":503,"PHASE3":505,"PHASE4":507,"NA":520},{"trials":500,"activeCount":71},[],{"trials":502,"activeCount":71},[],{"trials":504,"activeCount":71},[],{"trials":506,"activeCount":71},[],{"trials":508,"activeCount":71},[509],{"nctId":510,"briefTitle":511,"status":284,"phases":512,"primaryCompletion":513,"completion":514,"start":515,"enrollment":516,"conditions":517,"interventions":519},"NCT02724852","MMR Vaccination Among HIV-infected Adults",[63],"2013-09","2014-03","2011-07",632,[518],"HIV",[497],{"trials":521,"activeCount":71},[],{"intervention":523,"totalTrials":67,"cells":524},"Desflurane",{"EARLY_PHASE1":525,"PHASE1":527,"PHASE2":529,"PHASE3":531,"PHASE4":533,"NA":548},{"trials":526,"activeCount":71},[],{"trials":528,"activeCount":71},[],{"trials":530,"activeCount":71},[],{"trials":532,"activeCount":71},[],{"trials":534,"activeCount":71},[535],{"nctId":536,"briefTitle":537,"status":261,"phases":538,"primaryCompletion":539,"completion":539,"start":540,"enrollment":541,"conditions":542,"interventions":546},"NCT03006250","The Effect of Desflurane vs Sevoflurane on Perioperative Respiratory Complications in Laryngeal Mask Airway Anesthesia",[63],"2019-07","2016-08",220,[543,544,545],"Anesthesia; Adverse Effect","Laryngeal Masks","Respiratory System Abnormalities",[523,547],"Sevoflurane",{"trials":549,"activeCount":71},[],{"intervention":547,"totalTrials":67,"cells":551},{"EARLY_PHASE1":552,"PHASE1":554,"PHASE2":556,"PHASE3":558,"PHASE4":560,"NA":566},{"trials":553,"activeCount":71},[],{"trials":555,"activeCount":71},[],{"trials":557,"activeCount":71},[],{"trials":559,"activeCount":71},[],{"trials":561,"activeCount":71},[562],{"nctId":536,"briefTitle":537,"status":261,"phases":563,"primaryCompletion":539,"completion":539,"start":540,"enrollment":541,"conditions":564,"interventions":565},[63],[543,544,545],[523,547],{"trials":567,"activeCount":71},[],{"intervention":569,"totalTrials":67,"cells":570},"Spironolactone",{"EARLY_PHASE1":571,"PHASE1":573,"PHASE2":575,"PHASE3":577,"PHASE4":579,"NA":593},{"trials":572,"activeCount":71},[],{"trials":574,"activeCount":71},[],{"trials":576,"activeCount":71},[],{"trials":578,"activeCount":71},[],{"trials":580,"activeCount":71},[581],{"nctId":582,"briefTitle":583,"status":261,"phases":584,"primaryCompletion":585,"completion":586,"start":587,"enrollment":588,"conditions":589,"interventions":591},"NCT03953950","Effect of Add-on Spironolactone to Losartan Versus Losartan Alone on Peritoneal Membrane Among Peritoneal Dialysis Patients",[63],"2020-09","2020-12","2019-10",84,[590,29],"End Stage Renal Disease",[569,592],"Losartan",{"trials":594,"activeCount":71},[],{"intervention":592,"totalTrials":67,"cells":596},{"EARLY_PHASE1":597,"PHASE1":599,"PHASE2":601,"PHASE3":603,"PHASE4":605,"NA":611},{"trials":598,"activeCount":71},[],{"trials":600,"activeCount":71},[],{"trials":602,"activeCount":71},[],{"trials":604,"activeCount":71},[],{"trials":606,"activeCount":71},[607],{"nctId":582,"briefTitle":583,"status":261,"phases":608,"primaryCompletion":585,"completion":586,"start":587,"enrollment":588,"conditions":609,"interventions":610},[63],[590,29],[569,592],{"trials":612,"activeCount":71},[],{"intervention":614,"totalTrials":67,"cells":615},"Tranexamic acid",{"EARLY_PHASE1":616,"PHASE1":618,"PHASE2":620,"PHASE3":622,"PHASE4":624,"NA":637},{"trials":617,"activeCount":71},[],{"trials":619,"activeCount":71},[],{"trials":621,"activeCount":71},[],{"trials":623,"activeCount":71},[],{"trials":625,"activeCount":71},[626],{"nctId":627,"briefTitle":628,"status":261,"phases":629,"primaryCompletion":630,"completion":631,"start":632,"enrollment":633,"conditions":634,"interventions":636},"NCT04386642","Tranexamic Acid Reduce Blood Loss in Meningioma Resection",[63],"2022-07-31","2022-09-30","2021-09-01",44,[635],"Meningioma",[614],{"trials":638,"activeCount":71},[],{"intervention":640,"totalTrials":67,"cells":641},"Rilpivirine 25 mg",{"EARLY_PHASE1":642,"PHASE1":644,"PHASE2":646,"PHASE3":648,"PHASE4":650,"NA":663},{"trials":643,"activeCount":71},[],{"trials":645,"activeCount":71},[],{"trials":647,"activeCount":71},[],{"trials":649,"activeCount":71},[],{"trials":651,"activeCount":71},[652],{"nctId":653,"briefTitle":654,"status":261,"phases":655,"primaryCompletion":656,"completion":656,"start":657,"enrollment":658,"conditions":659,"interventions":662},"NCT03567304","Neurocognitive Function Improvement After Switching From Efavirenz to Rilpivirine",[63],"2020-07","2018-07-06",28,[660,661],"HIV-1-infection","Neurocognitive Dysfunction",[640],{"trials":664,"activeCount":71},[],{"intervention":666,"totalTrials":67,"cells":667},"Scalp block with 0.5% plain Marcaine",{"EARLY_PHASE1":668,"PHASE1":670,"PHASE2":672,"PHASE3":674,"PHASE4":676,"NA":690},{"trials":669,"activeCount":71},[],{"trials":671,"activeCount":71},[],{"trials":673,"activeCount":71},[],{"trials":675,"activeCount":71},[],{"trials":677,"activeCount":71},[678],{"nctId":679,"briefTitle":680,"status":284,"phases":681,"primaryCompletion":682,"completion":683,"start":684,"enrollment":685,"conditions":686,"interventions":688},"NCT02057367","Scalp Nerve Block and Opioid Consumption in Brain Surgery",[63],"2016-02","2016-04","2013-03",100,[687],"Brain Tumour",[666,689],"Scalp block with 0.9% normal saline",{"trials":691,"activeCount":71},[],{"intervention":689,"totalTrials":67,"cells":693},{"EARLY_PHASE1":694,"PHASE1":696,"PHASE2":698,"PHASE3":700,"PHASE4":702,"NA":708},{"trials":695,"activeCount":71},[],{"trials":697,"activeCount":71},[],{"trials":699,"activeCount":71},[],{"trials":701,"activeCount":71},[],{"trials":703,"activeCount":71},[704],{"nctId":679,"briefTitle":680,"status":284,"phases":705,"primaryCompletion":682,"completion":683,"start":684,"enrollment":685,"conditions":706,"interventions":707},[63],[687],[666,689],{"trials":709,"activeCount":71},[],{"intervention":711,"totalTrials":67,"cells":712},"Tamsulosin Hydrochloride OCAS 0.4 mg",{"EARLY_PHASE1":713,"PHASE1":715,"PHASE2":717,"PHASE3":719,"PHASE4":721,"NA":731},{"trials":714,"activeCount":71},[],{"trials":716,"activeCount":71},[],{"trials":718,"activeCount":71},[],{"trials":720,"activeCount":71},[],{"trials":722,"activeCount":71},[723],{"nctId":724,"briefTitle":725,"status":261,"phases":726,"primaryCompletion":727,"start":288,"enrollment":225,"conditions":728,"interventions":730},"NCT01167062","Efficacy of Tamsulosin Oral-controlled Absorption System (OCAS) in the Treatment of Distal Ureteral Stones",[63],"2011-04",[729],"Ureteral Calculi",[711],{"trials":732,"activeCount":71},[],{"intervention":734,"totalTrials":67,"cells":735},"dexmedetomidine 5 mcg mixed with 0.5% plain bupivacaine",{"EARLY_PHASE1":736,"PHASE1":738,"PHASE2":740,"PHASE3":742,"PHASE4":744,"NA":757},{"trials":737,"activeCount":71},[],{"trials":739,"activeCount":71},[],{"trials":741,"activeCount":71},[],{"trials":743,"activeCount":71},[],{"trials":745,"activeCount":71},[746],{"nctId":747,"briefTitle":748,"status":261,"phases":749,"primaryCompletion":750,"completion":751,"start":752,"enrollment":753,"conditions":754,"interventions":756},"NCT04785222","Infraorbital Nerve Block for Endoscopic Transsphenoidal Approach to Remove Pituitary Tumor",[63],"2023-07","2023-12","2021-07",63,[755],"Intraoperative Pain Control",[734],{"trials":758,"activeCount":71},[],{"intervention":760,"totalTrials":67,"cells":761},"Recombinant Hepatitis B vaccine [(CIGB) La Habana, Cuba]",{"EARLY_PHASE1":762,"PHASE1":764,"PHASE2":766,"PHASE3":768,"PHASE4":770,"NA":780},{"trials":763,"activeCount":71},[],{"trials":765,"activeCount":71},[],{"trials":767,"activeCount":71},[],{"trials":769,"activeCount":71},[],{"trials":771,"activeCount":71},[772],{"nctId":773,"briefTitle":774,"status":284,"phases":775,"primaryCompletion":682,"completion":682,"start":776,"enrollment":777,"conditions":778,"interventions":779},"NCT02732054","Hepatitis B Vaccination in HIV-infected Adults With Low CD4 Cell Counts",[63],"2015-03",16,[21],[760],{"trials":781,"activeCount":71},[],{"intervention":783,"totalTrials":67,"cells":784},"Mevac-A vaccine",{"EARLY_PHASE1":785,"PHASE1":787,"PHASE2":789,"PHASE3":791,"PHASE4":804,"NA":806},{"trials":786,"activeCount":71},[],{"trials":788,"activeCount":71},[],{"trials":790,"activeCount":71},[],{"trials":792,"activeCount":71},[793],{"nctId":794,"briefTitle":795,"status":284,"phases":796,"primaryCompletion":797,"completion":797,"start":798,"enrollment":225,"conditions":799,"interventions":802},"NCT06298708","Immunogenicity and Safety of Inactivated and Live-attenuated HAV Vaccine Among Thai Healthy Children and Adolescents",[62],"2024-12-09","2024-04-27",[800,18,801,15],"HAV","Hep A",[783,803],"Havrix 720 Junior",{"trials":805,"activeCount":71},[],{"trials":807,"activeCount":71},[],{"intervention":803,"totalTrials":67,"cells":809},{"EARLY_PHASE1":810,"PHASE1":812,"PHASE2":814,"PHASE3":816,"PHASE4":822,"NA":824},{"trials":811,"activeCount":71},[],{"trials":813,"activeCount":71},[],{"trials":815,"activeCount":71},[],{"trials":817,"activeCount":71},[818],{"nctId":794,"briefTitle":795,"status":284,"phases":819,"primaryCompletion":797,"completion":797,"start":798,"enrollment":225,"conditions":820,"interventions":821},[62],[800,18,801,15],[783,803],{"trials":823,"activeCount":71},[],{"trials":825,"activeCount":71},[],{"intervention":827,"totalTrials":67,"cells":828},"Simethicone 80 MG",{"EARLY_PHASE1":829,"PHASE1":831,"PHASE2":833,"PHASE3":835,"PHASE4":847,"NA":849},{"trials":830,"activeCount":71},[],{"trials":832,"activeCount":71},[],{"trials":834,"activeCount":71},[],{"trials":836,"activeCount":71},[837],{"nctId":838,"briefTitle":839,"status":284,"phases":840,"primaryCompletion":841,"completion":842,"start":843,"enrollment":225,"conditions":844,"interventions":846},"NCT03429621","Effect of Simethicone on Reducing Bowel Interference During Tubal Resection",[62],"2019-02-28","2019-03-31","2018-03-08",[845],"Sterility, Postpartum",[827],{"trials":848,"activeCount":71},[],{"trials":850,"activeCount":71},[],{"intervention":852,"totalTrials":67,"cells":853},"Intravenous iron",{"EARLY_PHASE1":854,"PHASE1":856,"PHASE2":858,"PHASE3":860,"PHASE4":875,"NA":877},{"trials":855,"activeCount":71},[],{"trials":857,"activeCount":71},[],{"trials":859,"activeCount":71},[],{"trials":861,"activeCount":71},[862],{"nctId":863,"briefTitle":864,"status":261,"phases":865,"primaryCompletion":866,"completion":630,"start":867,"enrollment":868,"conditions":869,"interventions":873},"NCT04464850","Intravenous Versus Oral Iron Therapy in Hemodialysis Patients",[62],"2021-01-31","2020-07-29",124,[870,871,872],"Hemodialysis Complication","Anemia","Iron Deficiency Anemia",[852,874],"Oral iron",{"trials":876,"activeCount":71},[],{"trials":878,"activeCount":71},[],{"intervention":874,"totalTrials":67,"cells":880},{"EARLY_PHASE1":881,"PHASE1":883,"PHASE2":885,"PHASE3":887,"PHASE4":893,"NA":895},{"trials":882,"activeCount":71},[],{"trials":884,"activeCount":71},[],{"trials":886,"activeCount":71},[],{"trials":888,"activeCount":71},[889],{"nctId":863,"briefTitle":864,"status":261,"phases":890,"primaryCompletion":866,"completion":630,"start":867,"enrollment":868,"conditions":891,"interventions":892},[62],[870,871,872],[852,874],{"trials":894,"activeCount":71},[],{"trials":896,"activeCount":71},[],{"intervention":898,"totalTrials":67,"cells":899},"quetiapine",{"EARLY_PHASE1":900,"PHASE1":902,"PHASE2":904,"PHASE3":906,"PHASE4":920,"NA":922},{"trials":901,"activeCount":71},[],{"trials":903,"activeCount":71},[],{"trials":905,"activeCount":71},[],{"trials":907,"activeCount":71},[908],{"nctId":909,"briefTitle":910,"status":911,"phases":912,"primaryCompletion":727,"completion":913,"start":914,"enrollment":915,"conditions":916,"interventions":918},"NCT00954603","A Double-blind, Randomized, Controlled Trial of Quetiapine Versus Haloperidol for the Treatment of Delirium","TERMINATED",[62],"2012-07","2009-06",52,[917],"Delirium",[898,919],"haloperidol",{"trials":921,"activeCount":71},[],{"trials":923,"activeCount":71},[],{"intervention":919,"totalTrials":67,"cells":925},{"EARLY_PHASE1":926,"PHASE1":928,"PHASE2":930,"PHASE3":932,"PHASE4":938,"NA":940},{"trials":927,"activeCount":71},[],{"trials":929,"activeCount":71},[],{"trials":931,"activeCount":71},[],{"trials":933,"activeCount":71},[934],{"nctId":909,"briefTitle":910,"status":911,"phases":935,"primaryCompletion":727,"completion":913,"start":914,"enrollment":915,"conditions":936,"interventions":937},[62],[917],[898,919],{"trials":939,"activeCount":71},[],{"trials":941,"activeCount":71},[],{"intervention":943,"totalTrials":67,"cells":944},"Spironolactone or hydrochlorothiazide",{"EARLY_PHASE1":945,"PHASE1":947,"PHASE2":949,"PHASE3":951,"PHASE4":962,"NA":964},{"trials":946,"activeCount":71},[],{"trials":948,"activeCount":71},[],{"trials":950,"activeCount":71},[],{"trials":952,"activeCount":71},[953],{"nctId":954,"briefTitle":955,"status":261,"phases":956,"primaryCompletion":630,"completion":957,"start":958,"enrollment":685,"conditions":959,"interventions":961},"NCT04465123","Early Sequential Nephron Blockade in Acute Heart Failure Patients: A Randomised, Controlled Study",[62],"2022-12-31","2020-08-13",[960,27],"Acute Heart Failure",[943],{"trials":963,"activeCount":71},[],{"trials":965,"activeCount":71},[],{"intervention":967,"totalTrials":67,"cells":968},"Hepavax-Gene",{"EARLY_PHASE1":969,"PHASE1":971,"PHASE2":973,"PHASE3":975,"PHASE4":987,"NA":989},{"trials":970,"activeCount":71},[],{"trials":972,"activeCount":71},[],{"trials":974,"activeCount":71},[],{"trials":976,"activeCount":71},[977],{"nctId":978,"briefTitle":979,"status":261,"phases":980,"primaryCompletion":981,"completion":982,"start":983,"enrollment":984,"conditions":985,"interventions":986},"NCT01289106","Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult Subjects",[62],"2011-10","2012-04","2011-01",132,[25],[967,967,967],{"trials":988,"activeCount":71},[],{"trials":990,"activeCount":71},[],{"intervention":992,"totalTrials":67,"cells":993},"Lidocaine spray",{"EARLY_PHASE1":994,"PHASE1":996,"PHASE2":998,"PHASE3":1000,"PHASE4":1012,"NA":1014},{"trials":995,"activeCount":71},[],{"trials":997,"activeCount":71},[],{"trials":999,"activeCount":71},[],{"trials":1001,"activeCount":71},[1002],{"nctId":1003,"briefTitle":1004,"status":284,"phases":1005,"primaryCompletion":1006,"completion":1006,"start":1007,"enrollment":1008,"conditions":1009,"interventions":1011},"NCT03075358","Effects of Lidocaine Spray for Reducing Pain During Endometrial Aspiration Biopsy : a Randomized Controlled Trial",[62],"2018-01-15","2017-03-06",240,[1010],"Uterine Bleeding",[992],{"trials":1013,"activeCount":71},[],{"trials":1015,"activeCount":71},[],{"intervention":1017,"totalTrials":67,"cells":1018},"Iodopovidone solution",{"EARLY_PHASE1":1019,"PHASE1":1021,"PHASE2":1023,"PHASE3":1025,"PHASE4":1037,"NA":1039},{"trials":1020,"activeCount":71},[],{"trials":1022,"activeCount":71},[],{"trials":1024,"activeCount":71},[],{"trials":1026,"activeCount":71},[1027],{"nctId":1028,"briefTitle":1029,"status":284,"phases":1030,"primaryCompletion":1031,"completion":1031,"start":1032,"enrollment":265,"conditions":1033,"interventions":1035},"NCT02674243","Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion",[62],"2019-12","2015-11",[1034],"Malignant Pleural Effusion",[1017,1036],"Talc",{"trials":1038,"activeCount":71},[],{"trials":1040,"activeCount":71},[],{"intervention":1036,"totalTrials":67,"cells":1042},{"EARLY_PHASE1":1043,"PHASE1":1045,"PHASE2":1047,"PHASE3":1049,"PHASE4":1055,"NA":1057},{"trials":1044,"activeCount":71},[],{"trials":1046,"activeCount":71},[],{"trials":1048,"activeCount":71},[],{"trials":1050,"activeCount":71},[1051],{"nctId":1028,"briefTitle":1029,"status":284,"phases":1052,"primaryCompletion":1031,"completion":1031,"start":1032,"enrollment":265,"conditions":1053,"interventions":1054},[62],[1034],[1017,1036],{"trials":1056,"activeCount":71},[],{"trials":1058,"activeCount":71},[],{"intervention":1060,"totalTrials":67,"cells":1061},"Dexmedetomidine",{"EARLY_PHASE1":1062,"PHASE1":1064,"PHASE2":1066,"PHASE3":1080,"PHASE4":1082,"NA":1084},{"trials":1063,"activeCount":71},[],{"trials":1065,"activeCount":71},[],{"trials":1067,"activeCount":71},[1068],{"nctId":1069,"briefTitle":1070,"status":284,"phases":1071,"primaryCompletion":1072,"completion":1072,"start":286,"enrollment":265,"conditions":1073,"interventions":1079},"NCT01289769","The Effect of Dexmedetomidine on Hemodynamic Response During Double Lumen Endotracheal Intubation",[61],"2011-12",[1074,1075,1076,31,1077,1078],"Intubation Complication","Tracheal Intubation Morbidity","Anesthesia Intubation Complication","High Blood Pressure","Tachycardia",[1060],{"trials":1081,"activeCount":71},[],{"trials":1083,"activeCount":71},[],{"trials":1085,"activeCount":71},[],{"intervention":1087,"totalTrials":67,"cells":1088},"Parecoxib",{"EARLY_PHASE1":1089,"PHASE1":1091,"PHASE2":1093,"PHASE3":1106,"PHASE4":1108,"NA":1110},{"trials":1090,"activeCount":71},[],{"trials":1092,"activeCount":71},[],{"trials":1094,"activeCount":71},[1095],{"nctId":1096,"briefTitle":1097,"status":284,"phases":1098,"primaryCompletion":1099,"completion":489,"start":1100,"enrollment":1101,"conditions":1102,"interventions":1105},"NCT01288924","Can Parecoxib Reduce Post-operative Ipsilateral Shoulder Pain?",[61],"2015-10","2011-02",160,[1103,1104],"Shoulder Pain","Post-operative Pain",[1087],{"trials":1107,"activeCount":71},[],{"trials":1109,"activeCount":71},[],{"trials":1111,"activeCount":71},[],{"intervention":1113,"totalTrials":67,"cells":1114},"Propofol",{"EARLY_PHASE1":1115,"PHASE1":1117,"PHASE2":1119,"PHASE3":1121,"PHASE4":1123,"NA":1125},{"trials":1116,"activeCount":71},[],{"trials":1118,"activeCount":71},[],{"trials":1120,"activeCount":71},[],{"trials":1122,"activeCount":71},[],{"trials":1124,"activeCount":71},[],{"trials":1126,"activeCount":71},[1127],{"nctId":1128,"briefTitle":1129,"status":284,"phases":1130,"primaryCompletion":1131,"completion":1131,"start":1132,"enrollment":1133,"conditions":1134,"interventions":1139},"NCT03910556","Re-craniotomy and Complications After Elective Neurosurgery",[],"2019-02","2017-01",439,[1135,1136,1137,1138],"Brain Tumor","Brain Metastases","Brain Cancer","Brain Neoplasms",[1113],{"intervention":1141,"totalTrials":67,"cells":1142},"Topical antibiotics following",{"EARLY_PHASE1":1143,"PHASE1":1145,"PHASE2":1147,"PHASE3":1149,"PHASE4":1151,"NA":1153},{"trials":1144,"activeCount":71},[],{"trials":1146,"activeCount":71},[],{"trials":1148,"activeCount":71},[],{"trials":1150,"activeCount":71},[],{"trials":1152,"activeCount":71},[],{"trials":1154,"activeCount":71},[1155],{"nctId":1156,"briefTitle":1157,"status":261,"phases":1158,"primaryCompletion":1159,"completion":1159,"start":1160,"enrollment":1161,"conditions":1162,"interventions":1164},"NCT02810587","Endophthalmitis After Intravitreous Anti-VEGF Injections in Patients Receiving vs. Not Receiving Topical Antibiotics",[],"2017-04","2015-05",5000,[1163],"Endophthalmitis",[1141],{"intervention":269,"totalTrials":67,"cells":1166},{"EARLY_PHASE1":1167,"PHASE1":1169,"PHASE2":1171,"PHASE3":1173,"PHASE4":1175,"NA":1177},{"trials":1168,"activeCount":71},[],{"trials":1170,"activeCount":71},[],{"trials":1172,"activeCount":71},[],{"trials":1174,"activeCount":71},[],{"trials":1176,"activeCount":71},[],{"trials":1178,"activeCount":71},[1179],{"nctId":259,"briefTitle":260,"status":261,"phases":1180,"primaryCompletion":263,"completion":263,"start":264,"enrollment":265,"conditions":1181,"interventions":1182},[64],[267],[47,269],{"intervention":1184,"totalTrials":67,"cells":1185},"angiotensin-converting enzyme inhibitor",{"EARLY_PHASE1":1186,"PHASE1":1188,"PHASE2":1190,"PHASE3":1192,"PHASE4":1194,"NA":1196},{"trials":1187,"activeCount":71},[],{"trials":1189,"activeCount":71},[],{"trials":1191,"activeCount":71},[],{"trials":1193,"activeCount":71},[],{"trials":1195,"activeCount":71},[],{"trials":1197,"activeCount":71},[1198],{"nctId":1199,"briefTitle":1200,"status":261,"phases":1201,"primaryCompletion":1202,"completion":1203,"start":1204,"enrollment":1205,"conditions":1206,"interventions":1207},"NCT04076930","Effects of Renin-Angiotensin System Inhibitors in Peritoneal Dialysis Patients",[],"2020-01","2020-03","2019-08-31",1468,[29],[1184],{"intervention":1209,"totalTrials":67,"cells":1210},"1mg 17 beta-estradiol",{"EARLY_PHASE1":1211,"PHASE1":1213,"PHASE2":1215,"PHASE3":1217,"PHASE4":1219,"NA":1221},{"trials":1212,"activeCount":71},[],{"trials":1214,"activeCount":71},[],{"trials":1216,"activeCount":71},[],{"trials":1218,"activeCount":71},[],{"trials":1220,"activeCount":71},[],{"trials":1222,"activeCount":71},[1223],{"nctId":1224,"briefTitle":1225,"status":284,"phases":1226,"primaryCompletion":1227,"completion":1228,"start":1229,"enrollment":685,"conditions":1230,"interventions":1232},"NCT02086032","The Effect of Different Types of Progestin on Sleeping of Menopausal Women",[64],"2015-06","2015-07","2014-01",[1231],"Menopausal and Postmenopausal Disorders",[1209,1233,1234],"Dydrogesterone","micronized progesterone",{"intervention":1233,"totalTrials":67,"cells":1236},{"EARLY_PHASE1":1237,"PHASE1":1239,"PHASE2":1241,"PHASE3":1243,"PHASE4":1245,"NA":1247},{"trials":1238,"activeCount":71},[],{"trials":1240,"activeCount":71},[],{"trials":1242,"activeCount":71},[],{"trials":1244,"activeCount":71},[],{"trials":1246,"activeCount":71},[],{"trials":1248,"activeCount":71},[1249],{"nctId":1224,"briefTitle":1225,"status":284,"phases":1250,"primaryCompletion":1227,"completion":1228,"start":1229,"enrollment":685,"conditions":1251,"interventions":1252},[64],[1231],[1209,1233,1234],{"intervention":1234,"totalTrials":67,"cells":1254},{"EARLY_PHASE1":1255,"PHASE1":1257,"PHASE2":1259,"PHASE3":1261,"PHASE4":1263,"NA":1265},{"trials":1256,"activeCount":71},[],{"trials":1258,"activeCount":71},[],{"trials":1260,"activeCount":71},[],{"trials":1262,"activeCount":71},[],{"trials":1264,"activeCount":71},[],{"trials":1266,"activeCount":71},[1267],{"nctId":1224,"briefTitle":1225,"status":284,"phases":1268,"primaryCompletion":1227,"completion":1228,"start":1229,"enrollment":685,"conditions":1269,"interventions":1270},[64],[1231],[1209,1233,1234],{"intervention":1272,"totalTrials":67,"cells":1273},"Hydrocortisone",{"EARLY_PHASE1":1274,"PHASE1":1276,"PHASE2":1278,"PHASE3":1280,"PHASE4":1282,"NA":1284},{"trials":1275,"activeCount":71},[],{"trials":1277,"activeCount":71},[],{"trials":1279,"activeCount":71},[],{"trials":1281,"activeCount":71},[],{"trials":1283,"activeCount":71},[],{"trials":1285,"activeCount":71},[1286],{"nctId":1287,"briefTitle":1288,"status":284,"phases":1289,"primaryCompletion":367,"completion":367,"start":1290,"enrollment":1291,"conditions":1292,"interventions":1295},"NCT03748537","Mitochondrial Function in Septic Patients",[64],"2017-01-01",20,[1293,1294],"Sepsis","Septic Shock",[1272],{"intervention":1297,"totalTrials":67,"cells":1298},"Aflibercept",{"EARLY_PHASE1":1299,"PHASE1":1301,"PHASE2":1303,"PHASE3":1305,"PHASE4":1307,"NA":1309},{"trials":1300,"activeCount":71},[],{"trials":1302,"activeCount":71},[],{"trials":1304,"activeCount":71},[],{"trials":1306,"activeCount":71},[],{"trials":1308,"activeCount":71},[],{"trials":1310,"activeCount":71},[1311],{"nctId":1312,"briefTitle":1313,"status":261,"phases":1314,"primaryCompletion":1315,"completion":1316,"start":1317,"enrollment":187,"conditions":1318,"interventions":1320},"NCT04707027","Interval of Disease Inactivity After Complete Polypoidal Regression in PCV Receiving Aflibercept",[64],"2022-11","2023-11","2020-11-01",[1319],"Polypoidal Choroidal Vasculopathy",[1297]]